Our article aims to report the ocular adverse effects of highly active antiretroviral therapy (HAART). In case 1, a 26-year-old male patient presented with a diminution of vision. In the absence of active cytomegalovirus (CMV) retinitis and a surge in CD4 count of more than 100 cells/µL over four months, he was diagnosed as a case of immune recovery uveitis (IRU). He responded well to topical steroids and cycloplegics. In case 2, while dry eye is a common adverse effect of HAART, our 53-year-old female patient progressed to a visually distressing stage of keratoconjunctivitis sicca. She responded to lubricants and continues to be on the same. In case 3, a 14-year-old female patient’s vision succumbed to Stevens-Johnson syndrome due to nevirapine in the absence of timely intervention. Though uncommon, debilitating ocular adverse effects may be seen with HAART. Further studies and reporting are required for an increased awareness among physicians and patients.
Cureus, Rare Ocular Involvement in a Newly Diagnosed AIDS Patient With Diffuse Kaposi's Sarcoma
PDF] Iatrogenic Cushing's Syndrome Following Intra-Articular Triamcinolone Injection in an HIV-Infected Patient on Cobicistat Presenting as a Pulmonary Embolism: Case Report and Literature Review
Cureus, A Diagnostic Challenge: Periorbital or Orbital Cellulitis?
PDF) Ocular diseases in HIV infection
Drug-Induced Pigmentation: Practice Essentials, Pathophysiology, Etiology
Hematologic Disorders
PDF) Ocular manifestations of COVID-19
Viruses, Free Full-Text
PDF) Ocular syphilis
Adverse reactions following MPox (monkeypox) vaccination: An overview from the Dutch and global adverse event reporting systems - Boom - 2023 - British Journal of Clinical Pharmacology - Wiley Online Library
Cureus Journal (u/CureusJournal) - Reddit
thought to be secondary to a mid-aortic
Kaposi sarcoma in unusual locations – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Changes in eyes after antiretroviral therapy in HIV patients
Advances in Our Understanding of the Interaction of Drugs with T-cells: Implications for the Discovery of Biomarkers in Severe Cutaneous Drug Reactions